Table 2.
Assessment of Persistent/Recurrent Disease in First 3 Years in Patients With and Without TgAb at Initial Thyroid Cancer Diagnosis
| Characteristic | Totala | TgAb Negativea | TgAb Positivea | P b |
|---|---|---|---|---|
| Number (%) | 61 | 36 (59) | 25 (41) | |
| Age at diagnosis, y | 14.8 (6.1–18.9) | 14.8 (6.1–18.9) | 14.7 (7.5–17.6) | 0.77 |
| Duration of follow-up, mo | 36 (17–36) | 36 (17–36) | 36 (26–36) | 0.006 |
| Diagnosis <3 years prior to end of study | 13 (21) | 3 (8) | 10 (40) | 0.004 |
| Disease status | 0.02 | |||
| No evidence of disease | 36 [59] | 26 [72] | 10 [40] | |
| Persistent recurrent disease | 25 [41] | 10 [28] | 15 [60] |
a
N [% of column total] or median (minimum to maximum).
b
Testing for difference in distribution of characteristic between antibody-positive and antibody-negative patients, by Wilcoxon rank sum or Fisher’s exact test.